MicroRNA-141 regulates the tumor suppressor DLC1 in colorectal cancer

Neoplasma

Volumn 62, Issue 5, 2015, Pages 705-712

  Wu, P P ^a   Zhu, H Y ^a   Sun, X F ^a   Chen, L X ^a   Zhou, Q ^a   Chen, J ^a  

^a JIANGSU CANCER HOSPITAL   (China)

Author keywords

Colorectal cancer; DLC1; miR 141

Indexed keywords

MICRORNA 141; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASSAY; BIOINFORMATICS; CELL CYCLE PROGRESSION; CELL GROWTH; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CLINICAL ARTICLE; COLORECTAL CANCER; COLORECTAL CANCER CELL LINE; CONTROLLED STUDY; DELETED IN LIVER CANCER 1 GENE; DOWN REGULATION; FLOW CYTOMETRY; GENE EXPRESSION; GENE OVEREXPRESSION; GENE REPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; LUCIFERASE ASSAY; MALE; METABOLIC INHIBITION; MOUSE; MTT ASSAY; NONHUMAN; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; TRANSWELL ASSAY; TUMOR SUPPRESSOR GENE; UPREGULATION; WESTERN BLOTTING;

EID: 84943641869     PISSN: 00282685     EISSN: 13384317     Source Type: Journal    
DOI: 10.4149/neo_2015_084     Document Type: Article

References (42)

1. YUAN BZ, MILLER MJ, KECK CL, ZIMONJIC DB, THORGEIRSSON SS, et al. Cloning, characterization, and chromosomal localization of a gene frequently deleted in hu¬man liver cancer (DLC1) homologous to rat RhoGAP. Cancer Res 1998; 58: 2196-2199.
2. DURKIN ME, YUAN BZ, ZHOU X, ZIMONJIC DB, LOWY DR, et al. DLC1: a Rho GTPase-activating protein and tumour [16] suppressor. J Cell Mol Med 2007; 11:1185-1207. http://dx.doi.org/10.1111/i.1582-4934.2007.00098.x
3. QIN Y, CHU B, GONG W, WANG J, TANG Z, et al. The inhibitory effects of deleted in liver cancer 1 gene on gallbladder cancer growth through induction of cell cycle arrest and apoptosis. J Gastroenterol Hepatol2014; 29: 964-972. http://dx.doi.org/10.1111/jgh.12486
4. XUE W, KRASNITZ A, LUCITO R, SORDELLA R, VANAELST L, et al. DLC1 is a chromosome 8p tumor suppressor whose loss promotes hepatocellular carcinoma. Genes Dev 2008; 22: 1439-1444. http://dx.doi.org/10.1101/gad.1672608
5. WANG C, WANG J, LIU H, FU Z. Tumor suppressor DLC1 induces apoptosis and inhibits the growth and invasion of co¬lon cancer cells through the Wnt/p-catenin signaling pathway. Oncol Rep 2014; 31: 2270-2278. http://dx.doi.org/10.3892/or.2014.3057
6. WU PP，JIN YL, SHANG YF, JIN Z, WU P, et al. Restoration of DLC1 gene inhibits proliferation and migration of human co¬lon cancer HT29 cells. Ann Clin Lab Sci 2009; 39: 263-269.
7. JIN Y, TIAN X, SHANG Y, HUANG P. Inhibition of DLC1 gene expression by RNA interference in the colon cancer LoVo cell line. Oncol Rep 2008; 19: 669-674. http://dx.doi.org/10.3892/or.19.3.669
8. KIM TY, HEALY KD, DER CJ, SCIAKY N, BANG YJ, et al. Effects of structure of Rho GTPase-activating protein DLC1 on cell morphology and migration. J Biol Chem 2008; 283: 32762-32770. http://dx.doi.org/10.1074/jbc.M800617200
9. LI G, DU X, VASS WC, PAPAGEORGE AG, LOWY DR, et al. Full activity of the deleted in liver cancer 1 (DLC1) tumor sup¬pressor depends on an LD-like motif that binds talin and focal adhesion kinase (FAK). Proc Natl Acad Sci U S A 2011; 108: 17129-17134. http://dx.doi.org/10.1073/pnas.1112122108
10. KIM TY, VIGIL D, DER CJ, JULIANO RL. Role of DLC1, a tumor suppressor protein with RhoGAP activity, in regula¬tion of the cytoskeleton and cell motility. Cancer Metastasis Rev 2009; 28: 77-78. http://dx.doi.org/10.1007/s10555-008-9167-2
11. LAHOZ A, HALL A. DLC1: a significant GAP in the cancer genome. Genes Dev 2008; 22: 1724-1730. http://dx.doi.org/10.1101/gad.1691408
12. BARRAS D, WIDMANN C. GAP-independent functions of DLC1 in metastasis. Cancer Metastasis Rev 2014; 33: 87-100. http://dx.doi.org/10.1007/s10555-013-9458-0
13. YANG X, POPESCU NC, ZIMONJIC DB. DLC1 interaction with S100A10 mediates inhibition of in vitro cell invasion and tumorigenicity of lung cancer cells through a RhoGAP- independent mechanism. Cancer Res 2011; 71: 2916-2925. http://dx.doi.org/10.1158/0008-5472.CAN-10-2158
14. KO FC, PING YAM JW. Regulation of deleted in liver cancer 1 tumor suppressor by protein-protein interactions and phos¬phorylation. Int J Cancer 2014; 135: 264-269. http://dx.doi.org/10.1002/ijc.28505
15. HE L, HANNON GJ. MicroRNAs: small RNAs with a big role in gene regulation. Nat Rev Genet 2004; 5: 522-531. http://dx.doi.org/10.1038/nrg1379
16. GARZON R, CALIN GA, CROCE CM. MicroRNAs in Cancer. Annu Rev Med 2009; 60: 167-179. http://dx.doi.org/10.1146/annurev.med.59.053006.104707
17. BANAUDHA K, KALISZEWSKI M, KOROLNEK T, FLO- REA L, YEUNG ML, et al. MicroRNA silencing of tumor suppressor DLC1 promotes efficient hepatitis C virus repli¬cation in primary human hepatocytes. Hepatology 2011; 53: 53-61. http://dx.doi.org/10.1002/hep.24016
18. PACURARI M, ADDISON JB, BONDALAPATI N, WAN YW, LUO D, et al. The microRNA-200 family targets multiple non-small cell lung cancer prognostic markers in H1299 cells and BEAS-2B cells. Int J Oncol 2013; 43: 548-560.
19. CHUNG JW, HONG SJ, KIM KJ, GOTI D, STINS MF, et al. 37-kDa laminin receptor precursor modulates cytotoxic necrotizing factor 1-mediated RhoA activation and bacterial uptake. J Biol Chem 2003; 278: 16857-16862. http://dx.doi.org/10.1074/jbc.M301028200
20. KIM CH, KWON S, BAHN JH, LEE K, JUN SI, et al. Effects of atmospheric nonthermal plasma on invasion of colorectal cancer cells. Appl Phys Lett 2010; 96: 243701. http://dx.doi.org/10.1063/1.3449575
21. WAN HY, GUO LM, LIU T, LIU M, LI X, et al. Regulation of the transcription factor NF-kappaB1 by microRNA-9 in hu¬man gastric adenocarcinoma. Mol Cancer 2010; 9: 16. http://dx.doi.org/10.1186/1476-4598-9-16
22. IORIO MV, VISONE R, DI LEVA G, DONATI V, PETROCCA F, et al. MicroRNA signatures in human ovar¬ian cancer. Cancer Res 2007; 67: 8699-8707. http://dx.doi.org/10.1158/0008-5472.CAN-07-1936
23. CHENG H, ZHANG L, COGDELL DE, ZHENG H, SCHETTER AJ, et al. Circulating plasma MiR-141 is a novel biomarker for metastatic colon cancer and predicts poor prog¬nosis. PLoS One 2011; 6: e17745. http://dx.doi.org/10.1371/journal.pone.0017745
24. PORKKA KP, PFEIFFER MJ, WALTERING KK, VESSELLA RL, TAMMELA TL, et al. MicroRNA expression profiling in prostate cancer. Cancer Res 2007; 67:6130-6135. http://dx.doi.org/10.1158/0008-5472.CAN-07-0533
25. YEH TS, WANG F, CHEN TC, YEH CN, YU MC, et al. Expression profile of microRNA-200 family in hepatocellular carcinoma with bile duct tumor thrombus. Ann Surg 2014; 259: 346-354. http://dx.doi.org/10.1097/SLA.0000000000000223
26. ZHAO G, WANG B, LIU Y, ZHANG JG, DENG SC, et al. miRNA-141, downregulated in pancreatic cancer, inhibits cell proliferation and invasion by directly targeting MAP4K4. Mol Cancer Ther 2013; 12: 2569-2580. http://dx.doi.org/10.1158/1535-7163.MCT-13-0296
27. NAKADA C, MATSUURA K, TSUKAMOTO Y, TANIGAWA M, YOSHIMOTO T, et al. Genome-wide microRNA expression profiling in renal cell carcinoma: significant down-regulation of miR-141 and miR-200c. J Pathol 2008; 216: 418-427. http://dx.doi.org/10.1002/path.2437
28. YU XY, ZHANG Z, LIU J, ZHAN B, KONG CZ. MicroRNA- 141 is downregulated in human renal cell carcinoma and regulates cell survival by targeting CDC25B. Onco Targets Ther 2013; 6: 349-354.
29. LIU Y, DING Y, HUANG J, WANG S, NI W, et al. MiR- 141 suppresses the migration and invasion of HCC cells by targeting Tiaml. PLoS One 2014; 9: e88393. http://dx.doi.org/10.1371/iournal.pone.0088393
30. DU Y, XU Y, DING L, YAO H, YU H, et al. Down-regulation of miR-141 in gastric cancer and its involvement in cell growth. J Gastroenterol 2009; 44: 556-561. http://dx.doi.org/10.1007/s00535-009-0037-7
31. ZHANG L, DENG T, LI X, LIU H, ZHOU H, et al. microRNA- 141 is involved in a nasopharyngeal carcinoma-related genes network. Carcinogenesis 2010; 31: 559-566. http://dx.doi.org/10.1093/carcin/bgp335
32. MATEESCU B, BATISTA L, CARDON M, GRUOSSO T, DE FERAUDY Y, et al. miR-141 and miR-200a act on ovarian tu¬morigenesis by controlling oxidative stress response. Nat Med 2011; 17: 1627-1635. http://dx.doi.org/10.1038/nm.2512
33. JIA Y, YANG Y, ZHAN Q, BROCK MV, ZHENG X, et al. Inhibition of SOX17 by microRNA 141 and methylation activates the WNT signaling pathway in esophageal cancer. J Mol Diagn 2012; 14: 577-585. http://dx.doi.org/10.1016/i.jmoldx.2012.06.004
34. MEI Z, HE Y, FENG J, SHI J, DU Y, et al. MicroRNA-141 promotes the proliferation of non-small cell lung cancer cells by regulating expression of PHLPP1 and PHLPP2. FEBS Lett 2014; 588: 3055-3061. http://dx.doi.org/10.1016/i.febslet.2014.06.020
35. HU M, XIA M, CHEN X, LIN Z, XU Y, et al. MicroRNA-141 regulates Smad interacting protein 1 (SIP1) and inhibits migra¬tion and invasion of colorectal cancer cells. Dig Dis Sci 2010; 55: 2365-2372. http://dx.doi.org/10.1007/s10620-009-1008-9
36. YIN J, BAI Z, SONG J, YANG Y, WANG J, et al. Differential expression of serum miR-126, miR-141 and miR-21 as novel biomarkers for early detection of liver metastasis in colorectal cancer. Chin J Cancer Res 2014; 26: 95-103.
37. WILSON PJ, MCGLINN E, MARSH A, EVANS T, ARNOLD J, et al. Sequence variants of DLC1 in colorectal and ovarian tumours. Hum Muta.2000; 15: 156-165. http://dx.doi.org/10.1002/(SICI)1098-1004(200002)15:2<156::AID-HUMU4>3.0.CO;2-4
38. YUAN BZ, DURKIN ME, POPESCU NC. Promoter hyper- methylation of DLC1, a candidate tumor suppressor gene, in several common human cancers. Cancer Genet Cytogenet 2003; 140: 113-117.http://dx.doi.org/10.1016/S0165-4608-(02)00674-X
39. GUAN M, ZHOU X, SOULITZIS N, SPANDIDOS DA, POPESCU NC. Aberrant methylation and deacetylation of deleted in liver cancer-1 gene in prostate cancer: potential clinical applications. Clin Cancer Res 2006; 12: 1412-1419. http://dx.doi.org/10.1158/1078-0432.CCR-05-1906
40. SCHOLZ RP, GUSTAFSSON JO, HOFFMANN P, JAISWAL M, AHMADIAN MR, et al. The tumor suppressor protein DLC1 is regulated by PKD-mediated GAP domain phos¬phorylation. Exp Cell Res 2011; 317: 496-503. http://dx.doi.org/10.1016/i.yexcr.2010.11.003
41. KO FC, CHAN LK, SZE KM, YEUNG YS, TSE EY, et al. PKA-induced dimerization of the RhoGAP DLC1 promotes its inhibition of tumorigenesis and metastasis. Nat Commun 2013; 4: 1618. http://dx.doi.org/10.1038/ncomms2604
42. KO FC, CHAN LK, TUNG EK, LOWE SW, NG IO, et al. Akt phosphorylation of deleted in liver cancer 1 abrogates its suppression of liver cancer tumorigenesis and metasta¬sis. Gastroenterology 2010; 139: 1397-1407. http://dx.doi.org/10.1053/i.gastro.2010.06.051